SOURCE: Intelleflex Corporation

Intelleflex Corporation

September 22, 2011 14:05 ET

Intelleflex to Share Insights on Ensuring Biopharmaceutical Product Integrity at IQPC's Cold Chain & Temperature Management Global Forum

Intelleflex Senior Director Tom Reese, Joined by Excellis Healthcare CEO Greg Cathcart, to Discuss the Business Benefits of In-Transit Condition Monitoring for Biopharmaceutical Couriers and Manufacturers

SANTA CLARA, CA--(Marketwire - Sep 22, 2011) - Intelleflex, a leading provider of on-demand data visibility solutions, today announced that Tom Reese, Senior Director at Intelleflex, will offer insights on utilizing in-transit temperature monitoring to ensure the efficacy and quality of biopharmaceuticals at the 9th Annual Cold Chain & Temperature Management Global Forum. Presented by Pharma IQ, a division of the International Quality & Productivity Center (IQPC), the Cold Chain & Temperature Management Global Forum will provide life science leaders and cold chain distribution professionals with the latest information and resources to remain ahead of the curve in the rapidly changing cold chain logistics landscape.

A former Motorola executive with vast cold chain experience, Reese will present "Ensuring Biopharmaceutical Product Integrity - Business Benefits of In-transit Condition Monitoring and Authentication" which takes place September 28, 4:00-4:40 pm, at the Pennsylvania Convention Center, in Philadelphia, Pennsylvania. His presentation will compare various options that couriers and manufacturers can utilize for condition monitoring and how new RFID solutions can monitor temperature and condition in-transit, without opening or unpacking the container, to create actionable data. This actionable data helps identify temperature change excursions before they become a problem, and helps to ensure that products are safe and effective for use with a documented quality record of conditions during transit and at final point of delivery.

Mr. Reese will discuss building and justifying the business case to support in-transit temperature monitoring and will be joined by Greg Cathcart, CEO of Excellis Healthcare, who will review a new case study designed to understand the positive economic impact on his clients' inventory by managing the visibility across the supply chain.

Who: Tom Reese, Senior Director, Intelleflex
What: Business Insights and Case Study Presentation
Topic: How Shippers are Ensuring Biopharmaceutical Product Integrity with In-transit Temperature Monitoring
Where: Pennsylvania Convention Center, Philadelphia, Pennsylvania
When: September 28, 2011; 4:00-4:40 pm

About Tom Reese
Reese has comprehensive experience in market development, sales and engineering from startups to large enterprises. Prior to Intelleflex, Reese led Motorola's Cold Chain Market Development and supported other industries including pharmaceuticals, healthcare, retail, transportation and logistics. Prior to Motorola, Reese founded a CRM software solutions company in the hospitality market.

About Intelleflex, Inc.
Intelleflex® provides on-demand, data visibility solutions for cold chain and asset management. Its industry-leading XC3 Technology™ RFID products enable a range of solutions for fresh produce, perishable food, and pharmaceutical temperature monitoring, asset tracking, personnel monitoring, retail, healthcare and other applications. These real-time monitoring solutions can help organizations reduce shrink or loss, more closely track and manage assets, reduce cost of operations, and increase profitability. For more information, visit www.intelleflex.com.

XC3 Technology is a trademark and Intelleflex is a registered trademark of Intelleflex Corporation. All other trademarked names in this document are the properties of their respective owners.

Contact Information